3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death

This disclosure relates to a novel class of compounds having the structure of formula I as defined herein and pharmaceutical compositions comprising a compound of formula I or a pharmaceutically acceptable salt thereof. This disclosure also comprises methods of treating a subject by administering a therapeutically effective amount of a compound of formula I or a pharmaceutically acceptable salt thereof to the subject. These compounds are useful for the conditions disclosed herein. This disclosure further comprises methods for making the compounds of formula I and corresponding intermediates.

Patent Publication Number: US9862678

Year filing: 2018

Year approval: 2018

Year publication: 2018

Status: Assigned

Technology domains: Organic fine chemistry

Validated for IOF-key: Yes

Attributed to: Associatie Universiteit & Hogescholen Antwerpen, Associatie Universiteit Gent